Does DAPRODUSTAT Cause Mobility decreased? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Mobility decreased have been filed in association with DAPRODUSTAT (Jesduvroq). This represents 0.7% of all adverse event reports for DAPRODUSTAT.
10
Reports of Mobility decreased with DAPRODUSTAT
0.7%
of all DAPRODUSTAT reports
2
Deaths
10
Hospitalizations
How Dangerous Is Mobility decreased From DAPRODUSTAT?
Of the 10 reports, 2 (20.0%) resulted in death, 10 (100.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPRODUSTAT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does DAPRODUSTAT Cause?
Hospitalisation (219)
Product use issue (116)
Off label use (105)
Death (91)
Haemoglobin decreased (65)
Cardiac failure (61)
Dysphagia (58)
Renal impairment (56)
Haemoglobin increased (53)
Marasmus (52)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DAPRODUSTAT Alternatives Have Lower Mobility decreased Risk?
DAPRODUSTAT vs DAPSONE
DAPRODUSTAT vs DAPTOMYCIN
DAPRODUSTAT vs DARATUMUMAB
DAPRODUSTAT vs DARATUMUMAB\HYALURONIDASE-FIHJ
DAPRODUSTAT vs DARBEPOETIN ALFA